Related Experiment Videos
Pathogen-free granulomatous diseases of the central nervous system
G Thomas1, S Murphy, H Staunton
1Department of Neuropathology, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin.
Abstract:
Pathogen-free granulomatous diseases (PFGD) of the central nervous system (CNS) are a group of disorders with protean clinical and pathological findings. Failure to identify a causative organism leads to considerable diagnostic difficulty. The neuropathology records between 1985 and 1995 were retrospectively reviewed, and the medical records of all patients in whom a diagnosis of PFGD of the CNS was made were retrieved. Patients in whom an infective agent was shown either by culture, special staining techniques, or by immunohistochemical methods were excluded. We identified 11 patients (eight male, three female) who fulfilled the pathological criteria for this condition. Average age at diagnosis was 38.7 years (range, 17 to 78). Neurological symptoms were the presenting feature in nine patients. Neuroimaging findings included hydrocephalus (54.5%), meningeal enhancement (45.5%), and mass lesions (45.5%). Seven patients had antemortem CNS biopsies (brain/meninges [n = 6], spinal [n = 1]), which showed noncaseating granulomas. Eight patients died (mortality rate: 72.7%). Postmortem examination showed granulomatous involvement of the leptomeninges and cerebral parenchyma in all cases with systemic involvement in 50%, chiefly in the form of noncaseating granulomas of the hilar nodes. Six patients fulfilled the clinical, radiological, and pathological diagnostic criteria for neurosarcoidosis. The remaining five patients had an unclassifiable pathogen-free granulomatous disease of the CNS. PFGD of the CNS are associated with a poor prognosis. Although neurosarcoidosis may account for some of the cases, there remains an unclassifiable subgroup that continues to be a diagnostic and management challenge.
Insights
Pathogen-free granulomatous diseases (PFGD) of the central nervous system (CNS) present diagnostic challenges. Many cases remain unclassifiable, highlighting a need for improved diagnostic and management strategies for these rare CNS disorders.
Area of Science:
- Neurology
- Pathology
- Immunology
Background:
- Pathogen-free granulomatous diseases (PFGD) of the central nervous system (CNS) are rare and challenging to diagnose due to diverse clinical and pathological presentations.
- Identifying a causative organism is often unsuccessful, complicating diagnosis and treatment.
Purpose of the Study:
- To retrospectively review cases of PFGD of the CNS to characterize their clinical, radiological, and pathological features.
- To identify potential subgroups within PFGD and assess diagnostic challenges.
Main Methods:
- Retrospective review of neuropathology and medical records from 1985-1995 for patients diagnosed with PFGD of the CNS.
- Exclusion of cases with identified infectious agents via culture, staining, or immunohistochemistry.
- Analysis of clinical presentation, neuroimaging, antemortem biopsies, and postmortem findings.
Main Results:
- Eleven patients met PFGD criteria, with a mean age of 38.7 years; 9 presented with neurological symptoms.
- Neuroimaging revealed hydrocephalus (54.5%), meningeal enhancement (45.5%), and mass lesions (45.5%).
- Seven patients underwent CNS biopsies showing noncaseating granulomas. Mortality rate was 72.7%. Six cases were classified as neurosarcoidosis, while five remained unclassifiable.
Conclusions:
- PFGD of the CNS are associated with a poor prognosis and significant diagnostic difficulties.
- While neurosarcoidosis accounts for some cases, a substantial unclassifiable subgroup persists, posing challenges for diagnosis and management.
- Further research is needed to elucidate the etiology and improve treatment strategies for unclassified PFGD of the CNS.